Alliqua BioMedical, Inc. (NASDAQ: ALQA) Skyrockets 168% After Announcing Plans to Spin-Off and Merger Contract Manufacturing Business With TO Pharmaceuticals, LLC

Alliqua BioMedical, Inc. (NASDAQ: ALQA) operates as a custom manufacturer within the medical device, cosmetics, OTC markets. Shares of the medical manufacturer are skyrocketing 168.08%, through early trading on Wednesday, November 28, 2018. Over the past three months, Alliqua BioMedical, Inc. has seen average daily volume of 13,278 shares. However, volume of 15.06 million shares or dollar volume of $59.94…

Read More

ePlay’s China Initiatives Continue On Multiple Fronts

ePlay China

Four significant projects identified with multiple partners in China   ePlay Digital Inc . ( CSE:EPY ) today announced that it has signed a number of preliminary agreements to pursue at least four significant sports related projects in China with potentially new strategic partners in China following a series of meetings with Chinese media, gaming, Internet, broadcast, and financing organizations.…

Read More

Q BioMed Inc Announces Acquisition of Cancer Pain Drug Metastron™ from GE Healthcare

Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries in Which Metastron™ is Already Registered and Approved for Sale NEW YORK, November 28, 2018 — Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, is pleased to announce that it has entered into agreement to acquire the metastatic skeletal cancer palliation drug, Metastron™,…

Read More